To the Editor: Tuch and Wall describe the process by the New South Wales Stem Cell Network in October 2012 of creating a national code of conduct for the self-regulation of autologous cell therapies.1 While Regeneus was an observer at the event, we were not involved in any discussions about industry self-regulation. Subsequently we were approached to participate in a committee to work on various topics, including a self-regulatory framework.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
No relevant disclosures.